/
Stock
/
/
APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-

OLEMA PHARMACEUTICALS

Trade OLMA
OLMA Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-12012243648600500k1 000k1 500k2 000k2 500k3 000k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-02-28
2025-03-03
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
650K
$0.00
1
$288.05M
2025-02-28
2025-03-03
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
A - Grant
Stock Option (Right to Buy)
320K
$0.00
1
$288.05M
2025-02-28
2025-03-03
MITCHELL SHAWNTE
CHIEF LEGAL OFFICER
A - Grant
Stock Option (Right to Buy)
450K
$0.00
1
$288.05M
2025-02-28
2025-03-03
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
A - Grant
Stock Option (Right to Buy)
205K
$0.00
1
$288.05M
2025-02-28
2025-03-03
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
205K
$0.00
1
$288.05M
2025-01-10
2025-01-14
BVF PARTNERS P/IL
A - Grant
Pre-Funded Warrant
420K
3
$288.05M
2025-01-10
2025-01-14
BVF PARTNERS P/IL
D - Sale to Issuer
Common stock, $0.0001 par value
-420K
3
$288.05M
2025-01-10
2025-01-13
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
J - Other
Common Stock
-3.50M
1
$288.05M
2025-01-10
2025-01-13
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
J - Other
Pre-Funded Warrant (right to buy)
3.50M
1
$288.05M
2025-01-08
2025-01-13
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
P - Purchase
Common Stock
300K
$6.00
1.80M
1
$288.05M
2024-12-13
2024-12-18
GRAHAM WALMSLEY
S - Sale
Common Stock
-701K
$7.00
-4.91M
1
$288.05M
2024-12-13
2024-12-18
GRAHAM WALMSLEY
P - Purchase
Common Stock
701K
$7.00
4.91M
1
$288.05M
2024-12-17
2024-12-17
GRAHAM WALMSLEY
P - Purchase
Common Stock
-701K
$7.00
-4.91M
1
$288.05M
2024-12-17
2024-12-17
GRAHAM WALMSLEY
S - Sale
Common Stock
-701K
$7.00
-4.91M
1
$288.05M
2024-12-16
2024-12-17
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
14,000
$5.00
70,000
1
$288.05M
2024-12-16
2024-12-17
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-14,000
$0.00
1
$288.05M
2024-12-13
2024-12-13
LOGOS OPPORTUNITIES FUND LP
S - Sale
-701K
$7.00
-4.91M
1
$288.05M
2024-12-11
2024-12-11
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-57,174
$9.00
-515K
2
$288.05M
2024-12-11
2024-12-11
HARMON CYRUS
S - Sale
Common Stock
-8,137
$9.00
-73,233
2
$288.05M
2024-12-11
2024-12-11
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
S - Sale
Common Stock
-18,356
$9.00
-165K
2
$288.05M
2024-12-11
2024-12-11
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-13,614
$9.00
-123K
2
$288.05M
2024-12-11
2024-12-11
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-14,522
$9.00
-131K
2
$288.05M
2024-12-11
2024-12-11
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-14,522
$9.00
-131K
2
$288.05M
2024-12-11
2024-12-11
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-13,614
$9.00
-123K
2
$288.05M
2024-12-11
2024-12-11
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
S - Sale
Common Stock
-18,356
$9.00
-165K
2
$288.05M
2024-12-11
2024-12-11
HARMON CYRUS
S - Sale
Common Stock
-8,137
$9.00
-73,233
2
$288.05M
2024-12-11
2024-12-11
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-57,174
$9.00
-515K
2
$288.05M
2024-12-10
2024-12-11
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
S - Sale
Common Stock
-16,803
$9.00
-151K
1
$288.05M
2024-12-10
2024-12-11
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-52,328
$9.00
-471K
1
$288.05M
2024-12-10
2024-12-11
HARMON CYRUS
S - Sale
Common Stock
-8,256
$9.00
-74,304
1
$288.05M
2024-12-10
2024-12-11
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-12,452
$9.00
-112K
1
$288.05M
2024-12-10
2024-12-11
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-13,283
$9.00
-120K
1
$288.05M
2024-12-09
2024-12-11
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
52,000
$0.00
1
$288.05M
2024-12-09
2024-12-11
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
A - Grant
Common Stock
48,750
$0.00
1
$288.05M
2024-12-09
2024-12-11
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
A - Grant
Common Stock
68,250
$0.00
1
$288.05M
2024-12-09
2024-12-11
HARMON CYRUS
A - Grant
Common Stock
29,250
$0.00
1
$288.05M
2024-12-09
2024-12-11
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Common Stock
205K
$0.00
1
$288.05M
2024-12-04
2024-12-04
BVF PARTNERS P/IL
A - Grant
Pre-Funded Warrant
5.83M
$4.00
23M
6
$288.05M
2024-12-04
2024-12-04
BVF PARTNERS P/IL
D - Sale to Issuer
Common stock, $0.0001 par value
-3.37M
3
$288.05M
2024-06-04
2024-11-26
GRAHAM WALMSLEY
S - Sale
Common Stock
-1.18M
$15.00
-18M
2
$288.05M
2024-11-15
2024-11-18
KOVACS SHANE WILLIAM CHARLES
Ch. Operating & Financial Off.
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$288.05M
2024-11-15
2024-11-18
KOVACS SHANE WILLIAM CHARLES
Ch. Operating & Financial Off.
M - Exercise
Common Stock
25,000
$7.00
175K
1
$288.05M
2024-08-01
2024-08-05
PARADIGM BIOCAPITAL ADVISORS LP
S - Sale
Common Stock, par value $0.0001 per share
-2.40M
$15.00
-36M
2
$288.05M
2024-07-30
2024-07-31
HARMON CYRUS
S - Sale
Common Stock
-934
$16.00
-14,944
1
$288.05M
2024-07-29
2024-07-31
HARMON CYRUS
S - Sale
Common Stock
-4,066
$16.00
-65,056
1
$288.05M
2024-07-11
2024-07-12
HARMON CYRUS
S - Sale
Common Stock
-5,000
$12.00
-60,000
1
$288.05M
2024-06-28
2024-07-02
HARMON CYRUS
S - Sale
Common Stock
-20,000
$11.00
-220K
1
$288.05M
2024-06-14
2024-06-18
HORNING SANDRA
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
HRUSTANOVIC GORJAN
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
LARSON YI
A - Grant
Stock Option (Right to Buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
RAPPAPORT ANDREW
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
BUTITTA CYNTHIA
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
BVF PARTNERS P/IL
A - Grant
Stock Option (Right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
CLARK IAN
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
GARLAND SCOTT
A - Grant
Stock Option (Right to Buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
GRAHAM WALMSLEY
A - Grant
Stock Option (right to buy)
23,000
$0.00
1
$288.05M
2024-06-14
2024-06-18
HARMON CYRUS
A - Grant
Stock Option (Right to Buy)
23,000
$0.00
1
$288.05M
2024-06-04
2024-06-06
LOGOS OPPORTUNITIES FUND II LP
S - Sale
-475K
$14.00
-6.65M
1
$288.05M
2024-06-04
2024-06-06
GRAHAM WALMSLEY
S - Sale
Common Stock
-1.18M
$15.00
-18M
2
$288.05M
2024-06-04
2024-06-06
LOGOS OPPORTUNITIES FUND LP
S - Sale
-700K
$14.00
-9.80M
1
$288.05M
2024-06-04
2024-06-04
HARMON CYRUS
S - Sale
Common Stock
-5,000
$12.00
-60,000
1
$288.05M
2024-06-03
2024-06-04
HARMON CYRUS
S - Sale
Common Stock
-5,000
$11.00
-55,000
1
$288.05M
2024-05-31
2024-06-04
HARMON CYRUS
S - Sale
Common Stock
-15,000
$9.00
-135K
1
$288.05M
2024-05-24
2024-05-28
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
9,460
$5.00
47,300
1
$288.05M
2024-05-24
2024-05-28
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-9,460
$0.00
1
$288.05M
2024-05-06
2024-05-07
HARMON CYRUS
S - Sale
Common Stock
-5,000
$11.00
-55,000
1
$288.05M
2024-04-30
2024-05-02
HARMON CYRUS
S - Sale
Common Stock
-15,000
$10.00
-150K
1
$288.05M
2024-03-28
2024-03-29
HARMON CYRUS
S - Sale
Common Stock
-20,000
$11.00
-220K
1
$288.05M
2024-03-18
2024-03-20
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
13,700
$5.00
68,500
1
$288.05M
2024-03-18
2024-03-20
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-13,700
$0.00
1
$288.05M
2024-03-05
2024-03-06
RAPPAPORT ANDREW
J - Other
Common Stock
386K
$0.00
1
$288.05M
2024-03-05
2024-03-06
RAPPAPORT ANDREW
J - Other
Common Stock
-481K
$0.00
1
$288.05M
2024-02-29
2024-03-04
HARMON CYRUS
S - Sale
Common Stock
-25,000
$12.00
-300K
2
$288.05M
2024-02-01
2024-02-05
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
195K
$0.00
1
$288.05M
2024-02-01
2024-02-05
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
A - Grant
Stock Option (Right to Buy)
305K
$0.00
1
$288.05M
2024-02-01
2024-02-05
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
622K
$0.00
1
$288.05M
2024-02-01
2024-02-05
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
A - Grant
Stock Option (Right to Buy)
195K
$0.00
1
$288.05M
2024-02-01
2024-02-02
HARMON CYRUS
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$288.05M
2024-01-31
2024-02-02
HARMON CYRUS
S - Sale
Common Stock
-25,000
$12.00
-300K
1
$288.05M
2024-01-25
2024-01-29
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
20,000
$7.00
140K
1
$288.05M
2024-01-25
2024-01-29
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$288.05M
2024-01-12
2024-01-16
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
M - Exercise
Common Stock
50,000
$7.00
350K
1
$288.05M
2024-01-12
2024-01-16
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
M - Exercise
Stock Option (Right to Buy)
-50,000
$0.00
1
$288.05M
2023-12-29
2024-01-02
HARMON CYRUS
S - Sale
Common Stock
-25,000
$13.00
-325K
2
$288.05M
2023-12-05
2023-12-18
GRAHAM WALMSLEY
P - Purchase
Common Stock
132K
$14.00
1.85M
3
$288.05M
2023-09-12
2023-12-18
GRAHAM WALMSLEY
P - Purchase
Common Stock
508K
$10.00
5.08M
1
$288.05M
2023-12-12
2023-12-12
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$288.05M
2023-12-12
2023-12-12
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
M - Exercise
Common Stock
10,000
$7.00
70,000
1
$288.05M
2023-12-11
2023-12-12
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-2,900
$0.00
1
$288.05M
2023-12-11
2023-12-12
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
2,900
$7.00
20,300
1
$288.05M
2023-12-06
2023-12-08
PARADIGM BIOCAPITAL ADVISORS LP
P - Purchase
Common Stock, par value $0.0001 per share
100K
$12.00
1.20M
1
$288.05M
2023-12-06
2023-12-07
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Stock Option (Right to Buy)
-13,100
$0.00
1
$288.05M
2023-12-06
2023-12-07
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
13,100
$7.00
91,700
1
$288.05M
2023-11-30
2023-12-01
HARMON CYRUS
S - Sale
Common Stock
-25,000
$13.00
-325K
1
$288.05M
2023-11-22
2023-11-22
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-7,095
$14.00
-99,330
1
$288.05M
2023-11-22
2023-11-22
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,653
$14.00
-93,142
1
$288.05M
2023-11-22
2023-11-22
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
S - Sale
Common Stock
-9,145
$14.00
-128K
1
$288.05M
2023-11-22
2023-11-22
HARMON CYRUS
S - Sale
Common Stock
-3,989
$14.00
-55,846
1
$288.05M
2023-11-22
2023-11-22
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-27,932
$14.00
-391K
1
$288.05M
2023-11-21
2023-11-22
HARMON CYRUS
S - Sale
Common Stock
-4,192
$15.00
-62,880
1
$288.05M
2023-11-21
2023-11-22
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-29,293
$15.00
-439K
2
$288.05M
2023-11-21
2023-11-22
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
S - Sale
Common Stock
-9,597
$15.00
-144K
2
$288.05M
2023-11-21
2023-11-22
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,976
$15.00
-105K
2
$288.05M
2023-11-21
2023-11-22
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-7,461
$15.00
-112K
2
$288.05M
2023-11-20
2023-11-22
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
28,000
$0.00
1
$288.05M
2023-11-20
2023-11-22
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
A - Grant
Common Stock
26,250
$0.00
1
$288.05M
2023-11-20
2023-11-22
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
A - Grant
Common Stock
36,750
$0.00
1
$288.05M
2023-11-20
2023-11-22
HARMON CYRUS
A - Grant
Common Stock
15,750
$0.00
1
$288.05M
2023-11-20
2023-11-22
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Common Stock
110K
$0.00
1
$288.05M
2023-11-08
2023-11-13
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-200
$18.00
-3,600
1
$288.05M
2023-11-03
2023-11-10
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-541
$18.00
-9,738
1
$288.05M
2023-11-02
2023-11-10
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-3,332
$15.00
-49,980
1
$288.05M
2023-11-01
2023-11-10
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,668
$15.00
-100K
1
$288.05M
2023-11-03
2023-11-06
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-541
$18.00
-9,738
1
$288.05M
2023-11-02
2023-11-06
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-3,332
$15.00
-49,980
1
$288.05M
2023-11-01
2023-11-06
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,668
$15.00
-100K
1
$288.05M
2023-11-03
2023-11-05
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-541
$18.00
-9,738
1
$288.05M
2023-11-02
2023-11-05
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-3,332
$15.00
-49,980
1
$288.05M
2023-11-01
2023-11-05
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,668
$15.00
-100K
1
$288.05M
2023-11-03
2023-11-03
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-541
$18.00
-9,738
1
$288.05M
2023-11-02
2023-11-03
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-3,332
$15.00
-49,980
1
$288.05M
2023-11-01
2023-11-03
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-6,668
$15.00
-100K
1
$288.05M
2023-11-02
2023-11-02
HARMON CYRUS
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$288.05M
2023-10-31
2023-11-02
HARMON CYRUS
S - Sale
Common Stock
-25,000
$12.00
-300K
1
$288.05M
2023-10-16
2023-10-17
GARLAND SCOTT
A - Grant
Stock Option (Right to Buy)
35,867
$0.00
2
$288.05M
2023-09-29
2023-10-03
HARMON CYRUS
S - Sale
Common Stock
-25,000
$12.00
-300K
1
$288.05M
2023-09-19
2023-09-21
MYLES DAVID
CH. DISCOV. & NON-CLIN DEV OFF
S - Sale
Common Stock
-20,000
$13.00
-260K
1
$288.05M
2023-09-14
2023-09-14
BVF PARTNERS P/IL
J - Other
Common stock, $0.0001 par value
99,556
1
$288.05M
2023-09-12
2023-09-14
BVF PARTNERS P/IL
P - Purchase
Common stock, $0.0001 par value
1.51M
$10.00
15M
3
$288.05M
2023-09-05
2023-09-05
HARMON CYRUS
S - Sale
Common Stock
-10,000
$12.00
-120K
1
$288.05M
2023-08-31
2023-09-05
HARMON CYRUS
S - Sale
Common Stock
-15,000
$9.00
-135K
1
$288.05M
2023-08-16
2023-09-05
HARMON CYRUS
S - Sale
Common Stock
-15,000
$10.00
-150K
1
$288.05M
2023-08-16
2023-08-17
HARMON CYRUS
S - Sale
Common Stock
-15,000
$10.00
-150K
1
$288.05M
2023-07-20
2023-07-20
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-5,265
$9.00
-47,385
1
$288.05M
2023-07-18
2023-07-18
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-15,000
$9.00
-135K
1
$288.05M
2023-06-29
2023-06-29
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-7,500
$10.00
-75,000
1
$288.05M
2023-06-28
2023-06-28
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-12,851
$10.00
-129K
1
$288.05M
2023-06-27
2023-06-27
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-15,029
$9.00
-135K
1
$288.05M
2023-06-16
2023-06-21
CLARK IAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
BUTITTA CYNTHIA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
BVF PARTNERS P/IL
A - Grant
Stock Option (Right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
GRAHAM WALMSLEY
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
HORNING SANDRA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
HRUSTANOVIC GORJAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
LARSON YI
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-16
2023-06-21
RAPPAPORT ANDREW
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2023-06-15
2023-06-15
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-31
$9.00
-279
1
$288.05M
2023-06-14
2023-06-14
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-198
$9.00
-1,782
1
$288.05M
2023-06-13
2023-06-13
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-9,213
$9.00
-82,917
1
$288.05M
2023-06-12
2023-06-12
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-41,167
$9.00
-371K
1
$288.05M
2023-06-09
2023-06-09
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-65,000
$8.00
-520K
1
$288.05M
2023-06-08
2023-06-09
HARMON CYRUS
S - Sale
Common Stock
-10,000
$6.00
-60,000
1
$288.05M
2023-06-08
2023-06-08
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-15,000
$6.00
-90,000
1
$288.05M
2023-06-06
2023-06-07
HARMON CYRUS
S - Sale
Common Stock
-5,000
$6.00
-30,000
1
$288.05M
2023-06-05
2023-06-07
HARMON CYRUS
S - Sale
Common Stock
-5,000
$6.00
-30,000
1
$288.05M
2023-06-06
2023-06-06
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-10,000
$6.00
-60,000
1
$288.05M
2023-06-05
2023-06-05
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-10,023
$6.00
-60,138
1
$288.05M
2023-05-19
2023-05-19
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
S - Sale
-5,000
$7.00
-35,000
1
$288.05M
2023-04-06
2023-04-07
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
P - Purchase
Common Stock
10,000
1
$288.05M
2023-03-29
2023-03-29
HORN KINNEY
Chief Business Officer
S - Sale
-2,458
$4.00
-9,832
1
$288.05M
2023-02-01
2023-02-02
HORN KINNEY
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$288.05M
2023-02-01
2023-02-02
BOHEN SEAN
President and CEO
A - Grant
Stock Option (Right to Buy)
550K
$0.00
1
$288.05M
2023-02-01
2023-02-02
HARMON CYRUS
Chief Research Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$288.05M
2023-02-01
2023-02-02
KOVACS SHANE WILLIAM CHARLES
Ch. Operating & Financial Off.
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$288.05M
2023-02-01
2023-02-02
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$288.05M
2023-02-01
2023-02-02
MYLES DAVID
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$288.05M
2023-02-01
2023-02-02
ZOJWALLA NASEEM
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$288.05M
2022-09-21
2022-09-23
BOHEN SEAN
PRESIDENT AND CEO
P - Purchase
Common Stock
20,000
1
$288.05M
2022-09-21
2022-09-22
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Common Stock
20,000
1
$288.05M
2022-09-02
2022-09-06
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
P - Purchase
Common Stock
20,000
1
$288.05M
2022-06-17
2022-06-27
GRAHAM WALMSLEY
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
HORNING SANDRA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
HRUSTANOVIC GORJAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
RAPPAPORT ANDREW
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
LARSON YI
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
BUTITTA CYNTHIA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-17
2022-06-27
CLARK IAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
BUTITTA CYNTHIA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
CLARK IAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
GRAHAM WALMSLEY
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
HORNING SANDRA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
HRUSTANOVIC GORJAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
LARSON YI
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2022-06-16
2022-06-17
RAPPAPORT ANDREW
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2022-06-10
2022-06-14
BVF PARTNERS P/IL
P - Purchase
Common stock, $0.0001 par value
200K
$4.00
800K
2
$288.05M
2022-03-10
2022-03-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,253
$0.00
1
$288.05M
2022-03-10
2022-03-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,253
$2.00
10,506
1
$288.05M
2022-03-10
2022-03-14
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,253
$5.00
-26,265
1
$288.05M
2022-02-10
2022-02-14
HORN KINNEY
CHIEF BUSINESS OFFICER
D - Sale to Issuer
Common Stock
-5,251
1
$288.05M
2022-02-10
2022-02-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2022-02-10
2022-02-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2022-02-01
2022-02-03
BOHEN SEAN
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
812K
$0.00
1
$288.05M
2022-02-01
2022-02-03
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
A - Grant
Stock Option (Right to Buy)
105K
$0.00
1
$288.05M
2022-02-01
2022-02-03
HORN KINNEY
CHIEF BUSINESS OFFICER
A - Grant
Stock Option (Right to Buy)
133K
$0.00
1
$288.05M
2022-02-01
2022-02-03
KOVACS SHANE WILLIAM CHARLES
CH. OPERATING & FINANCIAL OFF.
A - Grant
Stock Option (Right to Buy)
247K
$0.00
1
$288.05M
2022-02-01
2022-02-03
KUSHNER PETER
CHIEF SCIENTIFIC OFFICER
A - Grant
Stock Option (Right to Buy)
61,750
$0.00
1
$288.05M
2022-02-01
2022-02-03
MORIARTY JOHN
EVP, CH. LEGAL OFFICER & SEC.
A - Grant
Stock Option (Right to Buy)
166K
$0.00
1
$288.05M
2022-02-01
2022-02-03
MYLES DAVID
CHIEF DEVELOPMENT OFFICER
A - Grant
Stock Option (Right to Buy)
119K
$0.00
1
$288.05M
2022-02-01
2022-02-03
ZOJWALLA NASEEM
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$288.05M
2022-01-10
2022-01-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2022-01-10
2022-01-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2022-01-10
2022-01-11
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$7.00
-36,757
1
$288.05M
2021-12-10
2021-12-14
MYLES DAVID
CHIEF DEVELOPMENT OFFICER
S - Sale
Common Stock
-10,000
$10.00
-100K
1
$288.05M
2021-12-10
2021-12-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2021-12-10
2021-12-14
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-12-10
2021-12-14
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$10.00
-52,510
1
$288.05M
2021-11-30
2021-12-02
BVF PARTNERS P/IL
P - Purchase
Common stock, $0.0001 par value
740K
$9.00
6.66M
3
$288.05M
2021-11-29
2021-12-01
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-400
$25.00
-10,000
1
$288.05M
2021-11-10
2021-11-12
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-27,668
$27.00
-747K
1
$288.05M
2021-11-10
2021-11-12
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-27,668
$0.00
2
$288.05M
2021-11-10
2021-11-12
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
27,668
$16.00
443K
2
$288.05M
2021-10-19
2021-10-21
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-12,000
$28.00
-336K
2
$288.05M
2021-10-14
2021-10-15
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$288.05M
2021-10-14
2021-10-15
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Common Stock
5,000
$5.00
25,000
1
$288.05M
2021-10-14
2021-10-15
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-5,000
$30.00
-150K
2
$288.05M
2021-10-11
2021-10-12
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$28.00
-147K
2
$288.05M
2021-10-11
2021-10-12
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2021-10-11
2021-10-12
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-09-27
2021-09-29
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-1,085
$0.00
1
$288.05M
2021-09-27
2021-09-29
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Common Stock
1,085
$5.00
5,425
1
$288.05M
2021-09-27
2021-09-29
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-1,085
$30.00
-32,550
1
$288.05M
2021-09-20
2021-09-21
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-12,000
$26.00
-312K
1
$288.05M
2021-09-10
2021-09-13
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2021-09-10
2021-09-13
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-09-10
2021-09-13
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$29.00
-152K
1
$288.05M
2021-09-08
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-2,631
$0.00
1
$288.05M
2021-09-08
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-2,631
$30.00
-78,930
1
$288.05M
2021-09-08
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Common Stock
2,631
$5.00
13,155
1
$288.05M
2021-09-07
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-413
$0.00
1
$288.05M
2021-09-07
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Common Stock
413
$5.00
2,065
1
$288.05M
2021-09-07
2021-09-09
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-413
$30.00
-12,390
1
$288.05M
2021-09-01
2021-09-03
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Common Stock
871
$5.00
4,355
1
$288.05M
2021-09-01
2021-09-03
BOHEN SEAN
PRESIDENT AND CEO
S - Sale
Common Stock
-871
$30.00
-26,130
1
$288.05M
2021-09-01
2021-09-03
BOHEN SEAN
PRESIDENT AND CEO
M - Exercise
Stock Option (Right to Buy)
-871
$0.00
1
$288.05M
2021-08-19
2021-08-20
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-12,000
$25.00
-300K
1
$288.05M
2021-08-10
2021-08-11
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$26.00
-137K
2
$288.05M
2021-08-10
2021-08-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2021-08-10
2021-08-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-07-20
2021-07-21
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-4,123
$26.00
-107K
1
$288.05M
2021-07-19
2021-07-21
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-7,877
$25.00
-197K
1
$288.05M
2021-07-12
2021-07-13
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-5,251
$0.00
1
$288.05M
2021-07-12
2021-07-13
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-07-12
2021-07-13
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$27.00
-142K
2
$288.05M
2021-06-18
2021-06-21
HARMON CYRUS
CHIEF TECHNOLOGY OFFICER
S - Sale
Common Stock
-12,000
$25.00
-300K
3
$288.05M
2021-06-10
2021-06-11
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-5,251
$30.00
-158K
3
$288.05M
2021-06-10
2021-06-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (right to buy)
-5,251
$0.00
1
$288.05M
2021-06-10
2021-06-11
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
5,251
$2.00
10,502
1
$288.05M
2021-06-09
2021-06-10
LARSON YI
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
RAPPAPORT ANDREW
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
BUTITTA CYNTHIA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
CLARK IAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
GRAHAM WALMSLEY
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
HORNING SANDRA
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-06-09
2021-06-10
HRUSTANOVIC GORJAN
A - Grant
Stock Option (right to buy)
21,520
$0.00
1
$288.05M
2021-03-31
2021-05-26
BVF PARTNERS P/IL
J - Other
Common stock, $0.0001 par value
99,556
1
$288.05M
2021-05-18
2021-05-19
HORN KINNEY
CHIEF BUSINESS OFFICER
S - Sale
Common Stock
-57,763
$24.00
-1.39M
2
$288.05M
2021-05-18
2021-05-19
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Common Stock
57,763
$2.00
116K
1
$288.05M
2021-05-18
2021-05-19
HORN KINNEY
CHIEF BUSINESS OFFICER
M - Exercise
Stock Option (Right to Buy)
-57,763
$0.00
1
$288.05M
2021-04-05
2021-04-06
LARSON YI
A - Grant
Stock Option (Right to Buy)
25,293
$0.00
2
$288.05M
2021-03-15
2021-03-16
HORN KINNEY
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$288.05M
2021-03-15
2021-03-16
BOHEN SEAN
President and CEO
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$288.05M
2020-11-23
2020-11-24
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Common Stock
1.73M
2
$288.05M
2020-11-23
2020-11-24
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series C Preferred Stock
-452K
$0.00
1
$288.05M
2020-11-23
2020-11-24
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series B Preferred Stock
-1.27M
$0.00
1
$288.05M
2020-11-23
2020-11-23
RAPPAPORT ANDREW
C - Conversion
Series A-1 Convertible Preferred Stock
-130K
1
$288.05M
2020-11-23
2020-11-23
RAPPAPORT ANDREW
C - Conversion
Common Stock
449K
2
$288.05M
2020-11-23
2020-11-23
CORMORANT ASSET MANAGEMENT, LP
P - Purchase
Common Stock
425K
$19.00
8.07M
1
$288.05M
2020-11-23
2020-11-23
GRAHAM WALMSLEY
P - Purchase
Common Stock
1.16M
$19.00
22M
1
$288.05M
2020-11-23
2020-11-23
MYLES DAVID
Chief Development Officer
C - Conversion
Common Stock
168K
2
$288.05M
2020-11-23
2020-11-23
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Series B Convertible Preferred Stock
-2.12M
1
$288.05M
2020-11-23
2020-11-23
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Series C Convertible Preferred Stock
-723K
1
$288.05M
2020-11-23
2020-11-23
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Common Stock
2.85M
1
$288.05M
2020-11-23
2020-11-23
GRAHAM WALMSLEY
C - Conversion
Series B Convertible Preferred Stock
-1.40M
1
$288.05M
2020-11-23
2020-11-23
GRAHAM WALMSLEY
C - Conversion
Series C Convertible Preferred Stock
-1.18M
1
$288.05M
2020-11-23
2020-11-23
GRAHAM WALMSLEY
C - Conversion
Common Stock
2.58M
2
$288.05M
2020-11-23
2020-11-23
HARMON CYRUS
Chief Technology Officer
C - Conversion
Series A Convertible Preferred Stock
-193K
2
$288.05M
2020-11-23
2020-11-23
HARMON CYRUS
Chief Technology Officer
C - Conversion
Common Stock
193K
2
$288.05M
2020-11-23
2020-11-23
KUSHNER PETER
Chief Scientific Officer
C - Conversion
Series A Convertible Preferred Stock
-229K
1
$288.05M
2020-11-23
2020-11-23
KUSHNER PETER
Chief Scientific Officer
C - Conversion
Series A-1 Convertible Preferred Stock
-130K
1
$288.05M
2020-11-23
2020-11-23
KUSHNER PETER
Chief Scientific Officer
C - Conversion
Common Stock
359K
2
$288.05M
2020-11-23
2020-11-23
MCCORMICK FRANK
C - Conversion
Series A Convertible Preferred Stock
-66,326
1
$288.05M
2020-11-23
2020-11-23
MCCORMICK FRANK
C - Conversion
Series A-1 Convertible Preferred Stock
-153K
1
$288.05M
2020-11-23
2020-11-23
MCCORMICK FRANK
C - Conversion
Common Stock
219K
2
$288.05M
2020-11-23
2020-11-23
MYLES DAVID
Chief Development Officer
C - Conversion
Series A Convertible Preferred Stock
-168K
2
$288.05M
2020-11-23
2020-11-23
RAPPAPORT ANDREW
C - Conversion
Series A Convertible Preferred Stock
-319K
1
$288.05M
2020-11-19
2020-11-20
BVF PARTNERS P/IL
P - Purchase
Common stock, $0.0001 par value
1.14M
$19.00
22M
3
$288.05M
2020-11-19
2020-11-20
BVF PARTNERS P/IL
C - Conversion
Series C Convertible Preferred Stock
-1.36M
$0.00
3
$288.05M
2020-11-19
2020-11-20
BVF PARTNERS P/IL
C - Conversion
Common stock, $0.0001 par value
5.22M
9
$288.05M
2020-11-19
2020-11-20
BVF PARTNERS P/IL
C - Conversion
Series A-1 Convertible Preferred Stock
-2.20M
$0.00
3
$288.05M
2020-11-19
2020-11-20
BVF PARTNERS P/IL
C - Conversion
Series B Convertible Preferred Stock
-1.66M
$0.00
3
$288.05M
2020-11-18
2020-11-20
BVF PARTNERS P/IL
A - Grant
Stock Option (Right to buy)
64,560
$0.00
3
$288.05M
2020-11-18
2020-11-20
HARMON CYRUS
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
1,076
$0.00
1
$288.05M
2020-06-01
2020-11-20
GRAHAM WALMSLEY
P - Purchase
Series B Convertible Preferred Stock
340K
$5.00
1.70M
1
$288.05M
2020-11-18
2020-11-19
RAPPAPORT ANDREW
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2020-11-18
2020-11-19
BOHEN SEAN
President and CEO
A - Grant
Stock Option (Right to Buy)
538K
$0.00
1
$288.05M
2020-11-18
2020-11-19
BUTITTA CYNTHIA
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2020-11-18
2020-11-19
CLARK IAN
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2020-11-18
2020-11-19
GRAHAM WALMSLEY
A - Grant
Stock Option (Right to Buy)
64,560
$0.00
3
$288.05M
2020-11-18
2020-11-19
HARMON CYRUS
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
179K
$0.00
1
$288.05M
2020-11-18
2020-11-19
HORN KINNEY
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
89,670
$0.00
1
$288.05M
2020-11-18
2020-11-19
HORNING SANDRA
A - Grant
Stock Option (Right to Buy)
86,083
$0.00
1
$288.05M
2020-11-18
2020-11-19
HRUSTANOVIC GORJAN
A - Grant
Stock Option (Right to Buy)
64,560
$0.00
3
$288.05M
2020-11-18
2020-11-19
KOVACS SHANE WILLIAM CHARLES
Ch. Operating & Financial Off.
A - Grant
Stock Option (Right to Buy)
108K
$0.00
1
$288.05M
2020-11-18
2020-11-19
KUSHNER PETER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
179K
$0.00
1
$288.05M
2020-11-18
2020-11-19
MCCORMICK FRANK
A - Grant
Stock Option (Right to Buy)
21,520
$0.00
1
$288.05M
2020-11-18
2020-11-19
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$288.05M
2020-11-18
2020-11-19
MYLES DAVID
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
179K
$0.00
1
$288.05M
2020-09-30
2020-11-19
GRAHAM WALMSLEY
P - Purchase
Series C Convertible Preferred Stock
1.18M
$11.00
13M
1
$288.05M
2020-09-23
2020-11-19
BOHEN SEAN
President and CEO
M - Exercise
Stock Option (Right to Buy)
-51,649
$0.00
1
$288.05M
2020-09-23
2020-11-19
BOHEN SEAN
President and CEO
M - Exercise
Common Stock
51,649
$5.00
258K
1
$288.05M
2020-09-19
2020-11-19
MORIARTY JOHN
EVP, Ch. Legal Officer & Sec.
A - Grant
Stock Option (Right to Buy)
252K
$0.00
1
$288.05M
2020-09-19
2020-11-19
BOHEN SEAN
President and CEO
A - Grant
Stock Option (Right to Buy)
1.11M
$0.00
2
$288.05M
2020-09-18
2020-11-19
RAPPAPORT ANDREW
A - Grant
Stock Option (Right to Buy)
56,964
$0.00
1
$288.05M
2020-09-18
2020-11-19
MCCORMICK FRANK
A - Grant
Stock Option (Right to Buy)
56,964
$0.00
1
$288.05M
2020-09-16
2020-11-19
BUTITTA CYNTHIA
M - Exercise
Stock Option (Right to Buy)
-83,876
$0.00
1
$288.05M
2020-09-16
2020-11-19
BUTITTA CYNTHIA
M - Exercise
Common Stock
83,876
$4.00
336K
1
$288.05M
2020-09-12
2020-11-19
HARMON CYRUS
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
228K
$0.00
1
$288.05M
2020-08-12
2020-11-19
BUTITTA CYNTHIA
A - Grant
Stock Option (Right to Buy)
83,876
$0.00
1
$288.05M
2020-08-12
2020-11-19
CLARK IAN
A - Grant
Stock Option (Right to Buy)
210K
$0.00
1
$288.05M
2020-06-15
2020-11-19
HARMON CYRUS
Chief Technology Officer
A - Grant
Common Stock
143K
$0.00
1
$288.05M
2020-06-15
2020-11-19
KUSHNER PETER
Chief Scientific Officer
A - Grant
Common Stock
143K
$0.00
1
$288.05M
2020-06-15
2020-11-19
MYLES DAVID
Chief Development Officer
A - Grant
Common Stock
143K
$0.00
1
$288.05M
2020-06-15
2020-11-19
KOVACS SHANE WILLIAM CHARLES
Ch. Operating & Financial Off.
A - Grant
Common Stock
359K
$0.00
1
$288.05M
2020-06-10
2020-11-19
HORN KINNEY
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
252K
$0.00
1
$288.05M
2020-06-01
2020-11-19
GRAHAM WALMSLEY
P - Purchase
Series B Convertible Preferred Stock
340K
$5.00
1.70M
1
$288.05M